2nd UCT LUPUS WORKSHOP FINAL PROGRAM

2nd AFRICA LUPUS GENETICS NETWORK (ALUGEN) WORKSHOP Thursday 17th MARCH 2016 UNIVERSITY OF CAPE TOWN Venue: Bill Hoffen...

0 downloads 75 Views 208KB Size
2nd AFRICA LUPUS GENETICS NETWORK (ALUGEN) WORKSHOP Thursday 17th MARCH 2016 UNIVERSITY OF CAPE TOWN

Venue: Bill Hoffenberg Lecture Theatre, J-floor, Old Main Building, Groote Schuur Hospital

08:55 – 09.00

WELCOME

SESSION 1: Chair:

Prof Charles Swanepoel

09:00 – 09:45

An update on kidney disease in systemic lupus erythematosus

09:45 - 10:05

Immunopathogenesis of SLE: of genes, immune regulation, and autoantibodies

10:05 – 10:25

10:25 – 10:45

Challenges in the management of children with SLE

Epidemiology and standard of care of Lupus nephritis in Africa

Dr. Bridget Hodkinson (UCT)

Prof. David Jayne (Cambridge)

Prof. Stan Ress (UCT) A/Prof. Chris Scot (UCT)

A/Prof. Ikechi Okpechi (UCT)

10:45 - 11:05

TEA (20 minutes)

SESSION 2: Chair:

Dr Ayanda Gcelu

11:05 - 11:25

Measuring outcomes in SLE: What are the best tools out there?

Dr. Bridget Hodkinson (UCT)

11:25 - 11:45

Lupus in the Eastern Cape: experiences and challenges of a nephrologist

Dr. Rob Freercks (UCT)

11:45 – 12:05

Addressing joint disorders and other musculoskeletal issues in SLE

Prof. Asgar Kalla (UCT)

12:05 - 13:00

LUNCH

SESSION 3: Chair:

Dr Bridget Hodkinson Dr Shepherd Kajawo (Medicine UCT) Dr Yazied Chotia (Tygerberg Hospital) Dr Avela Nkabane (UCT) Ms. Angel Phuti (UCT)

13:00 – 13:30

Abstracts (8 minutes each)

13:30 - 13:50

Dermatological manifestations of SLE

Dr. Sue Jessop (UCT)

13:50 – 14:20

FOCUS ON SLE RESEARCH: Dissecting the hot topics in lupus research around the world

Prof. David Jayne (Cambridge)

14:20 - 15:20

15:20

Case presentations (20 minutes each x3) TEA and CLOSE MEDICNE GRAND ROUND: Venue: Lecture theatre 2, E Floor, Groote Schuur Hospital

16:00 – 17:00

Dr. Phetho Mangena (Nephrology UCT) Dr. Alda Vermeulen (George Hospital) A/Prof Chris Scot (RXCH UCT) A/Prof Ikechi Okpechi (UCT)

Prof. David Jayne (Cambridge) Rapidly progressive glomerulonephritis: reducing risk of end stage renal disease